All In Biotech

Drug Trial Radar · NCT06339008

A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/ LY3650150 in Adult Participants With Perennial Allergic Rhinitis

Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 450 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

450

Planned (sponsor's estimate)

Start

Apr 26, 2024

Primary completion

Oct 22, 2026

Study completion Oct 2028

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Apr 1, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. Participants can expect study participation to last up to 29.5 months.

Conditions

  • Perennial Allergic Rhinitis (PAR)

Interventions

  • LY3650150Drug

    Administered SC

  • PlaceboDrug

    Administered SC

  • Standard therapy for INCSDrug

    Administered as intranasal spray

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change From Baseline (CFBL) in Total Nasal Symptom Score (TNSS) at Week 16Time frame: Baseline, Week 16

Locations

74 sites in 6 countries. Site status is shown where the registry gives one.

  • Allergy and Asthma Specialists Medical Group

    Huntington Beach, California

  • 310 Clinical Research

    Inglewood, California

  • Allergy & Asthma Associates of Southern California dba. Southern California Research

    Laguna Niguel, California

  • Allergy and Asthma

    San Diego, California

  • Asthma and Allergy Associates, PC

    Colorado Springs, Colorado

  • Allergy and Asthma Diagnostic Center

    Tallahassee, Florida

  • University of South Florida

    Tampa, Florida

  • Northwestern University

    Chicago, Illinois

  • Asthma Allergy Center of Chicago

    River Forest, Illinois

  • Bluegrass Allergy Research

    Lexington, Kentucky

  • Respiratory Medicine Research Institute of Michigan, PLC

    Ypsilanti, Michigan

  • Clinical Research Institute

    Minneapolis, Minnesota

  • University of Missouri Hospital

    Columbia, Missouri

  • Allergy and Asthma Consultants

    St Louis, Missouri

  • Asthma and Allergy Center

    Bellevue, Nebraska

  • Circuit Clinical/Hudson-Essex Allergy

    Belleville, New Jersey

  • Circuit Clinical/Mercer Allergy and Pulmonary Associates

    Hamilton, New Jersey

  • Dr. Patrick Perin

    Teaneck, New Jersey

  • Smith Allergy and Asthma

    Horseheads, New York

  • Allergy Partners

    Asheville, North Carolina

  • Bernstein Clinical Research Center, LLC

    Cincinnati, Ohio

  • Northwest Research Center

    Portland, Oregon

  • Allergy and Clinical Immunology Associates

    Pittsburgh, Pennsylvania

  • AARA Research Center

    Dallas, Texas

  • Kerrville Allergy and Asthma Associates

    Kerrville, Texas

  • Allergy, Asthma & Sinus Center

    Greenfield, Wisconsin

  • Hôpital Erasme, Service Pharmacie

    Brussels, Belgium

  • Pneumocare

    Erpent, Belgium

  • UZ Gent

    Ghent, Belgium

  • UZ Leuven, Pharmacy

    Leuven, Belgium

  • Hôpital de la Citadelle

    Liège, Belgium

  • Internal Medicine Building

    Beijing, China

  • Department of Nasal Allergy

    Beijing, China

  • The Third Xiangya Hospital of Central South University

    Changsha, China

  • GCP Pharmacy

    Guangzhou, China

  • Zhejiang People's Hospital

    Hangzhou, China

  • Jingzhou Central Hospital

    Jingzhou, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, China

  • The Second Affiliated Hospital of Nanchang University

    Nanchang, China

  • People's Hospital of Guangxi Zhuang Autonomous Region

    Nanning, China

Showing 40 of 74 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.